Doudna's work has led to CRISPR becoming a transformative technology in medicine, significantly advancing gene editing with real-world applications in treating diseases like sickle cell.
The FDA's approval of CRISPR-based therapies marks a milestone in gene editing, though the costs and challenges of effective delivery highlight the need for ongoing innovation.
Patients experiencing CRISPR-based treatments describe them as 'completely life-changing,' underscoring the technology's potential to revolutionize treatment landscapes in genetic diseases.
The Innovative Genomics Institute is at the forefront of making gene therapies more accessible, working to reduce costs and improve delivery methods for patients globally.
[
Collection
]
[
|
...
]